Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
MacroGenics
Bolt Biotherapeutics, Inc.
Tempus AI
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Ikena Oncology
Pfizer
Novartis
NuCana plc
University of California, San Diego
Eli Lilly and Company
Turnstone Biologics, Corp.
Seagen Inc.
Turnstone Biologics, Corp.
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Astellas Pharma Inc
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Novartis
ABM Therapeutics Corporation
Pfizer
Eisai Inc.
Fate Therapeutics
Oncorus, Inc.
Seagen Inc.
Nektar Therapeutics
Rubius Therapeutics
Repertoire Immune Medicines
Amgen
Genocea Biosciences, Inc.
Incyte Corporation
MacroGenics
Dynavax Technologies Corporation
Effector Therapeutics
Fore Biotherapeutics
Seagen Inc.
Incyte Corporation
Tocagen Inc.
Dartmouth-Hitchcock Medical Center
Celgene
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Celldex Therapeutics
Calando Pharmaceuticals
M.D. Anderson Cancer Center